Navigation Links
New Medicare model guidelines for benefit years 2012-2014 in development
Date:10/4/2010

Rockville, Md., October 4, 2010 As the Medicare Model Guidelinesa listing of therapeutic categories and pharmacologic classes that Medicare Part D plans can utilize when developing their formulariesundergo revision for the first time in three years, the U.S. Pharmacopeial Convention (USP) is announcing its revision schedule and the expanded opportunities for public input as it develops Version 5.0.

Medicare Model Guidelines Version 5.0 will be available for utilization by prescription drug plans for the plan years 2012�. USP, a nonprofit scientific organization that sets federally recognized standards for the quality of medicines, was charged with developing the guidelines for the Centers for Medicare and Medicaid Services (CMS) under the Medicare Prescription Drug Improvement and Modernization Act of 2003.

USP has maintained a public comment process and one-on-one manufacturer consultations for developing the USP Model Guidelines since the beginning of this activity in 2004. In this revision cycle, USP is initiating new public Open Microphone Web meetings to solicit specific feedback on the content and organization of the USP Model Guidelines (to be held November 4, 8, 11 and 16, 2010). The one-on-one manufacturer consultations will be held October 4󈝿, 2010, and are an opportunity for manufacturers to schedule 30-minute scientific and clinical presentations with USP scientific staff to present information related to their medicines. Information related to these activities can be found on www.usp.org, under "Model Guidelines."

The Medicare Model Guidelines, which were initially released annually, will be developed by the USP Model Guidelines Expert Panel consisting of clinical pharmacists and pharmacologists, formulary specialists, health care practitioners and academicians, providers, beneficiaries and other volunteer experts. The panel will deliberate on the categories and classes to be included in Version 5.0 to be used as a resource by drug plans, reviewing current scientific evidence related to newly approved drugs and indications.

The Expert Panel will release the draft USP Model Guidelines Version 5.0 for public comment through the USP Web site (www.usp.org) on November 1, 2010, commencing a 30-day public comment period closing November 30, 2010. The draft USP Model Guidelines Version 5.0 will be presented to USP's Nomenclature, Safety and Labeling Expert Committee, the Expert Committee to which the Expert Panel reports, for approval in mid-January 2011. The final USP Medicare Model Guidelines Version 5.0 will be presented to CMS in late January 2011, and posted on the USP Web site in early February 2011.


'/>"/>

Contact: Francine Pierson
fp@usp.org
301-816-8588
US Pharmacopeia
Source:Eurekalert

Related medicine news :

1. Medicare Cost-Saving Moves Can Backfire
2. Connecture, Inc. Announces Partnership with MedicareCRM
3. Medicare data reveals differences in orthopedic surgical outcomes
4. Hayes Announces Appointment Of Dr Susan Levine To The Medicare Evidence Development and Coverage Advisory Committee (MEDCAC)
5. Georgia Senators Urged to Stop Medicare Cut Before March 1 Deadline
6. Top-Rated Medicare Advantage Plan Reaches 27,000-Member Milestone
7. Pelosi Statement on Additional Aid to States In Medicare Part D Payments
8. Medicare Advantage Members May Make Changes During Open Enrollment
9. Partners Home Care Scores in Top Tier in National Medicare Demonstration Project
10. Study Suggests Low-Consuming Medicare Beneficiaries With Chronic Disease Are More Costly to Program
11. Senate Inaction On Medicare Hurts Seniors, Military and Boomers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class designers of Happy ... their novel lifesaving device for the everyday use of parents worldwide. It is ... to read a child’s vital signs, and detect unusual symptoms or physical patterns. ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... to be diagnosed globally; approximately 25,000 of them will be malignant.(1) As research ... of this type of healthcare model in the diagnosis and treatment of brain ...
(Date:4/24/2017)... ... ... Come to PAINWeekEnd (PWE) Tampa on May 20 and 21, at the Renaissance ... program. , An attendee at a recent PAINWeekEnd said, "Very helpful, wish we ... entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant Behavior, presented by Dr. Ted ...
(Date:4/24/2017)... ... ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues”: a guide to ... Navigate Life Issues” is the creation of published author, Rachel Jamerson, writer of 25 ... CONTACT USA, and former member of the American Association of Christian Counselors. Rachel ...
(Date:4/24/2017)... ... April 24, 2017 , ... Anaconda BioMed, ... neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS), today announced it ... as the product advances towards regulatory and clinical phases. , "This is another ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... Viverae ® , a leader in workplace ... IBM ® Watson Campaign Automation, implementing behavioral messaging ... a personalized experience. Through digital engagement, the platform prompts ... real time. The enhanced experience drives engagement by focusing ... they are in their journey to health. ...
(Date:4/18/2017)... DIEGO , April 18, 2017  Astute Medical, ... a case series to be presented at the 2017 ... which begins today and continues through April 22. Physicians ... IGFBP-7 , used to assess risk for acute kidney ... decompensated heart failure (ADHF). Elevated levels ...
(Date:4/18/2017)... April 18, 2017  Socionext Inc. and SOINN ... in 2016, in which Socionext extracts and delivers ... companies achieved initial results in reading ultrasound images ... Brain SOINN. The results will be introduced at ... 19-21, at booths 4505 & 4507. ...
Breaking Medicine Technology: